New Marketing Authorisation Procedures of Medicinal Products for Human Use to be launched in early January 2004
pr1566
19/12/2003
| On the 2nd January 2004, the Ministry of Health will be launching the | Marketing Authorisation Project for medicinal products on the Maltese market. This will coincide with the establishment of the Medicines Authority which will ensure that authorised products satisfy European standards of quality, safety and efficacy. The authorisation system will be in line with the Medicines Act (Act III of 2003). |
| Until November 2002, medicinal products were | registered in Malta by the submission of a valid Certificate of Pharmaceutical Product (CPP) to the Medicines Regulatory Unit. A list of products that were registered by this system until this date was compiled (Derogation list). |
| At the launch of the project, products on the | derogation list will be given a provisional marketing authorisation (PMA) after submission of valid applications, documents and the relevant market authorisation fees. |
| Submission of other documents will be required so | that a Marketing Authorisation is issued for these products in line with EU standards. |
| Marketing Authorisation Holders of products that are | not on the transition list and are authorised by the centralised procedure in the EU, may submit an application form for a national MA. The MA issued will be valid until the day of accession. On the 1st of May 2004 this national Authorisation will become inapplicable whilst the Central Authorisation will come into force. |
| For products that are not on the transition list and | are authorised in the EU by the national or mutual recognition procedure the mutual recognition procedure will be available after accession. |
| Products that are not on the derogation list and are | not authorised in any EU member state, will have the facility to apply for a national MA which will remain valid after the day of accession but only valid for the Maltese market. |
| Guidelines, application forms and details of documents to be | submitted will be published on the website of the Medicines Regualtory Unit (www.health.gov.mt/mru), in the publications section. |
Other Press Releases:
PR261936
STQARRIJA MILL-UFFIĊĊJU TAD-DEPUTAT PRIM MINISTRU U MINISTERU GĦAS-SAĦĦA I...
PR261935en